| Dr Razelle Joco Reyes, DO | |
|
500 Cherry St, Bluefield, WV 24701-3306 | |
| (304) 327-1666 | |
| Not Available |
| Full Name | Dr Razelle Joco Reyes |
|---|---|
| Gender | Female |
| Speciality | Hospitalist |
| Experience | 13 Years |
| Location | 500 Cherry St, Bluefield, West Virginia |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1154618056 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207R00000X | Internal Medicine | 2846 (West Virginia) | Secondary |
| 208M00000X | Hospitalist | 2846 (West Virginia) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Princeton Community Hospital | Princeton, WV | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Princeton Community Hospital Assn. Inc. | 3678482221 | 133 |
News Archive
With increasing concern over ambulance services Health Minister Daniel Andrews has admitted that there are gaps in Victoria's ambulance services and once new paramedics arrive the problem will be addressed under the government's regional ambulance policy.
Sen. Hillary Rodham Clinton (D-N.Y.), who is running for the Democratic presidential nomination, recently signed a pledge to commit to investing $50 billion by 2013 to fight HIV/AIDS domestically and worldwide, the New York Times reports. Clinton also plans to issue a formal policy on the disease, according to the Times (Seelye, "The Caucus," New York Times, 10/26).
Promising results from Phase II clinical trials and important biological advances in diagnosis and prognosis will be presented here, at the conference on Molecular Origins of Lung Cancer from Jan. 11-14, 2010. This conference is jointly sponsored by the AACR and the International Association for the Study of Lung Cancer.
Curis, Inc., a drug development company seeking to develop next generation targeted small molecule drug candidates for cancer treatment, today announced a positive outcome from a pivotal Phase II clinical trial conducted by Roche and Genentech, Curis' collaborator and a wholly owned member of the Roche Group, of GDC-0449, a first-in-class hedgehog pathway inhibitor, in patients with advanced basal cell carcinoma (BCC).
› Verified 5 days ago
| Entity Name | Princeton Community Hospital Assn. Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1093917643 PECOS PAC ID: 3678482221 Enrollment ID: O20031211000436 |
News Archive
With increasing concern over ambulance services Health Minister Daniel Andrews has admitted that there are gaps in Victoria's ambulance services and once new paramedics arrive the problem will be addressed under the government's regional ambulance policy.
Sen. Hillary Rodham Clinton (D-N.Y.), who is running for the Democratic presidential nomination, recently signed a pledge to commit to investing $50 billion by 2013 to fight HIV/AIDS domestically and worldwide, the New York Times reports. Clinton also plans to issue a formal policy on the disease, according to the Times (Seelye, "The Caucus," New York Times, 10/26).
Promising results from Phase II clinical trials and important biological advances in diagnosis and prognosis will be presented here, at the conference on Molecular Origins of Lung Cancer from Jan. 11-14, 2010. This conference is jointly sponsored by the AACR and the International Association for the Study of Lung Cancer.
Curis, Inc., a drug development company seeking to develop next generation targeted small molecule drug candidates for cancer treatment, today announced a positive outcome from a pivotal Phase II clinical trial conducted by Roche and Genentech, Curis' collaborator and a wholly owned member of the Roche Group, of GDC-0449, a first-in-class hedgehog pathway inhibitor, in patients with advanced basal cell carcinoma (BCC).
› Verified 5 days ago
| Entity Name | Integrated Health Care Providers, Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1225057185 PECOS PAC ID: 6204733520 Enrollment ID: O20031216000069 |
News Archive
With increasing concern over ambulance services Health Minister Daniel Andrews has admitted that there are gaps in Victoria's ambulance services and once new paramedics arrive the problem will be addressed under the government's regional ambulance policy.
Sen. Hillary Rodham Clinton (D-N.Y.), who is running for the Democratic presidential nomination, recently signed a pledge to commit to investing $50 billion by 2013 to fight HIV/AIDS domestically and worldwide, the New York Times reports. Clinton also plans to issue a formal policy on the disease, according to the Times (Seelye, "The Caucus," New York Times, 10/26).
Promising results from Phase II clinical trials and important biological advances in diagnosis and prognosis will be presented here, at the conference on Molecular Origins of Lung Cancer from Jan. 11-14, 2010. This conference is jointly sponsored by the AACR and the International Association for the Study of Lung Cancer.
Curis, Inc., a drug development company seeking to develop next generation targeted small molecule drug candidates for cancer treatment, today announced a positive outcome from a pivotal Phase II clinical trial conducted by Roche and Genentech, Curis' collaborator and a wholly owned member of the Roche Group, of GDC-0449, a first-in-class hedgehog pathway inhibitor, in patients with advanced basal cell carcinoma (BCC).
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Razelle Joco Reyes, DO 500 Cherry St, Bluefield, WV 24701-3306 Ph: (304) 327-1134 | Dr Razelle Joco Reyes, DO 500 Cherry St, Bluefield, WV 24701-3306 Ph: (304) 327-1666 |
News Archive
With increasing concern over ambulance services Health Minister Daniel Andrews has admitted that there are gaps in Victoria's ambulance services and once new paramedics arrive the problem will be addressed under the government's regional ambulance policy.
Sen. Hillary Rodham Clinton (D-N.Y.), who is running for the Democratic presidential nomination, recently signed a pledge to commit to investing $50 billion by 2013 to fight HIV/AIDS domestically and worldwide, the New York Times reports. Clinton also plans to issue a formal policy on the disease, according to the Times (Seelye, "The Caucus," New York Times, 10/26).
Promising results from Phase II clinical trials and important biological advances in diagnosis and prognosis will be presented here, at the conference on Molecular Origins of Lung Cancer from Jan. 11-14, 2010. This conference is jointly sponsored by the AACR and the International Association for the Study of Lung Cancer.
Curis, Inc., a drug development company seeking to develop next generation targeted small molecule drug candidates for cancer treatment, today announced a positive outcome from a pivotal Phase II clinical trial conducted by Roche and Genentech, Curis' collaborator and a wholly owned member of the Roche Group, of GDC-0449, a first-in-class hedgehog pathway inhibitor, in patients with advanced basal cell carcinoma (BCC).
› Verified 5 days ago